Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer Academic Article uri icon

Overview

MeSH Major

  • Aromatase
  • Estrogen Receptor beta
  • Urinary Bladder Neoplasms

abstract

  • This study provides evidence for the prognostic value of RXRG in breast cancer particularly the ER-positive tumours.

publication date

  • October 29, 2019

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1038/s41416-019-0589-0

PubMed ID

  • 31558802

Additional Document Info

start page

  • 776

end page

  • 785

volume

  • 121

number

  • 9